ANGLE (LON:AGL) Stock Rating Reaffirmed by Berenberg Bank

Berenberg Bank reissued their buy rating on shares of ANGLE (LON:AGL) in a research note published on Thursday, Marketbeat reports. Berenberg Bank currently has a GBX 70 ($0.94) price target on the stock.

ANGLE Stock Down 5.6 %

Shares of LON:AGL opened at GBX 8.21 ($0.11) on Thursday. The company has a quick ratio of 6.18, a current ratio of 5.19 and a debt-to-equity ratio of 17.22. ANGLE has a 52-week low of GBX 7.11 ($0.10) and a 52-week high of GBX 37.40 ($0.50). The company has a 50 day moving average of GBX 12.83 and a two-hundred day moving average of GBX 14.49. The company has a market capitalization of £26.49 million, a price-to-earnings ratio of -117.34 and a beta of 0.22.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.